Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 12 | 2016 | 145 | 1.990 |
Why?
|
| War-Related Injuries | 3 | 2017 | 3 | 1.180 |
Why?
|
| General Surgery | 2 | 2020 | 238 | 1.040 |
Why?
|
| Military Personnel | 3 | 2016 | 94 | 0.950 |
Why?
|
| Neutrophils | 4 | 2016 | 323 | 0.860 |
Why?
|
| Military Medicine | 4 | 2019 | 22 | 0.840 |
Why?
|
| Aviation | 2 | 2015 | 5 | 0.770 |
Why?
|
| Estrogens | 3 | 2016 | 200 | 0.740 |
Why?
|
| Publications | 1 | 2020 | 27 | 0.640 |
Why?
|
| Alcohol Drinking | 2 | 2015 | 278 | 0.610 |
Why?
|
| Mustard Gas | 1 | 2019 | 1 | 0.610 |
Why?
|
| Chemical Warfare Agents | 1 | 2019 | 7 | 0.610 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2015 | 2685 | 0.610 |
Why?
|
| Aging | 7 | 2007 | 742 | 0.610 |
Why?
|
| Ethanol | 4 | 2015 | 262 | 0.600 |
Why?
|
| Pseudomonas Infections | 2 | 2016 | 101 | 0.590 |
Why?
|
| Interleukin-6 | 4 | 2009 | 273 | 0.590 |
Why?
|
| Wounds and Injuries | 3 | 2021 | 267 | 0.570 |
Why?
|
| Occupational Exposure | 1 | 2019 | 88 | 0.550 |
Why?
|
| Abdominal Abscess | 2 | 2015 | 23 | 0.550 |
Why?
|
| Alcoholism | 3 | 2010 | 185 | 0.550 |
Why?
|
| Traumatology | 1 | 2017 | 32 | 0.540 |
Why?
|
| Digestive System Neoplasms | 1 | 2017 | 22 | 0.530 |
Why?
|
| Postoperative Complications | 3 | 2018 | 2454 | 0.520 |
Why?
|
| Wound Infection | 1 | 2016 | 17 | 0.520 |
Why?
|
| Central Nervous System Depressants | 2 | 2008 | 45 | 0.510 |
Why?
|
| Clinical Competence | 2 | 2019 | 809 | 0.510 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2017 | 85 | 0.510 |
Why?
|
| Lactates | 1 | 2015 | 37 | 0.490 |
Why?
|
| Vital Signs | 1 | 2016 | 36 | 0.480 |
Why?
|
| Guideline Adherence | 1 | 2017 | 239 | 0.470 |
Why?
|
| Head Injuries, Closed | 1 | 2015 | 12 | 0.470 |
Why?
|
| Combat Disorders | 1 | 2015 | 4 | 0.470 |
Why?
|
| Hypotension | 1 | 2015 | 71 | 0.470 |
Why?
|
| Neck Injuries | 1 | 2015 | 13 | 0.470 |
Why?
|
| Abdominal Injuries | 2 | 2015 | 51 | 0.450 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 147 | 0.450 |
Why?
|
| Triage | 1 | 2016 | 125 | 0.450 |
Why?
|
| Hematoma | 1 | 2015 | 108 | 0.430 |
Why?
|
| Hospital Mortality | 2 | 2021 | 445 | 0.430 |
Why?
|
| Abdomen | 2 | 2015 | 125 | 0.430 |
Why?
|
| Male | 26 | 2024 | 43928 | 0.430 |
Why?
|
| Drainage | 1 | 2015 | 168 | 0.430 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2015 | 114 | 0.420 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2015 | 134 | 0.420 |
Why?
|
| Cytokines | 3 | 2016 | 842 | 0.410 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 1075 | 0.410 |
Why?
|
| Cervical Vertebrae | 1 | 2015 | 181 | 0.410 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2015 | 244 | 0.400 |
Why?
|
| Urinary Bladder | 1 | 2015 | 250 | 0.400 |
Why?
|
| Spleen | 3 | 2009 | 435 | 0.400 |
Why?
|
| Female | 28 | 2024 | 47901 | 0.390 |
Why?
|
| Humans | 39 | 2024 | 92351 | 0.390 |
Why?
|
| Hemorrhage | 3 | 2019 | 290 | 0.380 |
Why?
|
| Interferon-gamma | 5 | 2009 | 455 | 0.380 |
Why?
|
| Digestive System Abnormalities | 1 | 2011 | 12 | 0.370 |
Why?
|
| Liver | 3 | 2011 | 1225 | 0.360 |
Why?
|
| Liver Failure | 1 | 2011 | 69 | 0.360 |
Why?
|
| Retrospective Studies | 10 | 2021 | 9694 | 0.350 |
Why?
|
| Wounds, Stab | 1 | 2011 | 12 | 0.350 |
Why?
|
| Suicide | 2 | 2024 | 151 | 0.350 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2011 | 85 | 0.350 |
Why?
|
| Interleukin-4 | 4 | 2005 | 131 | 0.340 |
Why?
|
| Empyema | 1 | 2010 | 9 | 0.340 |
Why?
|
| Thoracostomy | 1 | 2010 | 10 | 0.340 |
Why?
|
| Hospitalization | 2 | 2020 | 925 | 0.340 |
Why?
|
| Mass Screening | 1 | 2015 | 675 | 0.330 |
Why?
|
| Colitis, Ischemic | 1 | 2010 | 4 | 0.330 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2010 | 33 | 0.330 |
Why?
|
| Intussusception | 1 | 2010 | 16 | 0.330 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2010 | 46 | 0.320 |
Why?
|
| Hypertension, Portal | 1 | 2010 | 46 | 0.320 |
Why?
|
| Constipation | 1 | 2010 | 69 | 0.320 |
Why?
|
| Interleukin-2 | 3 | 2009 | 245 | 0.320 |
Why?
|
| Diverticulum, Esophageal | 1 | 2009 | 6 | 0.310 |
Why?
|
| Adult | 14 | 2021 | 27547 | 0.310 |
Why?
|
| Aerospace Medicine | 1 | 2008 | 17 | 0.300 |
Why?
|
| Hemangioma | 1 | 2008 | 65 | 0.290 |
Why?
|
| Disease Models, Animal | 4 | 2016 | 2450 | 0.290 |
Why?
|
| Mice, Inbred BALB C | 9 | 2014 | 1105 | 0.290 |
Why?
|
| Intestines | 1 | 2010 | 426 | 0.270 |
Why?
|
| Meningitis, Pneumococcal | 1 | 2007 | 4 | 0.270 |
Why?
|
| Acute-Phase Reaction | 1 | 2007 | 16 | 0.260 |
Why?
|
| Immunity, Innate | 2 | 2016 | 441 | 0.260 |
Why?
|
| Aromatase | 1 | 2006 | 12 | 0.260 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2007 | 705 | 0.250 |
Why?
|
| Mice | 13 | 2016 | 12133 | 0.250 |
Why?
|
| Condylomata Acuminata | 1 | 2005 | 15 | 0.240 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 696 | 0.240 |
Why?
|
| Pain Management | 2 | 2017 | 154 | 0.240 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 2366 | 0.240 |
Why?
|
| Homicide | 2 | 2024 | 49 | 0.240 |
Why?
|
| Trauma Centers | 2 | 2020 | 162 | 0.230 |
Why?
|
| Atrial Fibrillation | 2 | 2021 | 378 | 0.230 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 1191 | 0.220 |
Why?
|
| Liver Transplantation | 1 | 2011 | 1186 | 0.220 |
Why?
|
| Intimate Partner Violence | 1 | 2024 | 28 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3514 | 0.200 |
Why?
|
| Th2 Cells | 1 | 2004 | 148 | 0.200 |
Why?
|
| Th1 Cells | 1 | 2004 | 168 | 0.200 |
Why?
|
| Firearms | 1 | 2024 | 68 | 0.200 |
Why?
|
| Animals | 16 | 2016 | 28059 | 0.190 |
Why?
|
| Liver Neoplasms | 1 | 2008 | 764 | 0.190 |
Why?
|
| Adolescent | 5 | 2021 | 9495 | 0.190 |
Why?
|
| Lymphocytes | 2 | 2004 | 476 | 0.180 |
Why?
|
| Abdominal Pain | 2 | 2015 | 144 | 0.180 |
Why?
|
| United States | 6 | 2024 | 7367 | 0.180 |
Why?
|
| Immune Tolerance | 1 | 2004 | 360 | 0.180 |
Why?
|
| Erythrocyte Indices | 1 | 2021 | 9 | 0.180 |
Why?
|
| Injury Severity Score | 2 | 2011 | 150 | 0.170 |
Why?
|
| Young Adult | 5 | 2021 | 6629 | 0.170 |
Why?
|
| Time Factors | 4 | 2011 | 5431 | 0.170 |
Why?
|
| Hypersensitivity, Delayed | 3 | 2005 | 25 | 0.170 |
Why?
|
| Dendritic Cells | 1 | 2004 | 478 | 0.160 |
Why?
|
| Erythrocytes | 1 | 2021 | 251 | 0.160 |
Why?
|
| Survival Analysis | 3 | 2014 | 1512 | 0.160 |
Why?
|
| Tourniquets | 1 | 2019 | 8 | 0.150 |
Why?
|
| Emergency Responders | 1 | 2019 | 7 | 0.150 |
Why?
|
| Middle Aged | 9 | 2021 | 27045 | 0.150 |
Why?
|
| Vascular System Injuries | 1 | 2019 | 33 | 0.150 |
Why?
|
| Aged | 7 | 2021 | 19952 | 0.140 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2018 | 66 | 0.140 |
Why?
|
| Iraq | 1 | 2017 | 2 | 0.140 |
Why?
|
| Radiography | 2 | 2010 | 794 | 0.140 |
Why?
|
| Infusions, Parenteral | 1 | 2017 | 51 | 0.130 |
Why?
|
| Simulation Training | 1 | 2019 | 106 | 0.130 |
Why?
|
| Treatment Outcome | 5 | 2018 | 8730 | 0.130 |
Why?
|
| Ovariectomy | 1 | 2016 | 86 | 0.130 |
Why?
|
| Afghan Campaign 2001- | 1 | 2016 | 5 | 0.120 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2793 | 0.120 |
Why?
|
| Infection Control | 1 | 2017 | 128 | 0.120 |
Why?
|
| Child, Preschool | 2 | 2015 | 3806 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 413 | 0.120 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 210 | 0.120 |
Why?
|
| Pain Measurement | 1 | 2017 | 360 | 0.120 |
Why?
|
| Afghanistan | 1 | 2015 | 3 | 0.120 |
Why?
|
| Skull Fractures | 1 | 2015 | 27 | 0.120 |
Why?
|
| Immunologic Factors | 1 | 2016 | 175 | 0.120 |
Why?
|
| Glasgow Coma Scale | 1 | 2015 | 80 | 0.110 |
Why?
|
| Neurologic Examination | 1 | 2015 | 124 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 2016 | 160 | 0.110 |
Why?
|
| Age Factors | 3 | 2015 | 1904 | 0.110 |
Why?
|
| Immunity, Cellular | 2 | 2006 | 184 | 0.110 |
Why?
|
| Recurrence | 2 | 2009 | 1180 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2016 | 301 | 0.110 |
Why?
|
| Intracranial Hemorrhages | 1 | 2015 | 131 | 0.110 |
Why?
|
| Pneumonia, Bacterial | 1 | 2014 | 29 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1733 | 0.100 |
Why?
|
| Mice, Knockout | 2 | 2009 | 2098 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 617 | 0.100 |
Why?
|
| Biliary Fistula | 1 | 2012 | 11 | 0.100 |
Why?
|
| Yellow Fever Vaccine | 1 | 2012 | 2 | 0.100 |
Why?
|
| Yellow fever virus | 1 | 2012 | 7 | 0.100 |
Why?
|
| Intestinal Fistula | 1 | 2012 | 31 | 0.100 |
Why?
|
| Gallbladder Diseases | 1 | 2012 | 21 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 3376 | 0.100 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2012 | 7 | 0.090 |
Why?
|
| Diagnosis, Differential | 3 | 2012 | 1593 | 0.090 |
Why?
|
| Biomarkers | 2 | 2016 | 1847 | 0.090 |
Why?
|
| Colonic Diseases | 1 | 2012 | 61 | 0.090 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2012 | 53 | 0.090 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2012 | 52 | 0.090 |
Why?
|
| Cecal Neoplasms | 1 | 2011 | 5 | 0.090 |
Why?
|
| Child | 2 | 2015 | 7309 | 0.090 |
Why?
|
| Intestinal Diseases | 1 | 2011 | 80 | 0.090 |
Why?
|
| Giant Cells | 1 | 2010 | 19 | 0.090 |
Why?
|
| Appendicitis | 1 | 2011 | 65 | 0.090 |
Why?
|
| Laparotomy | 1 | 2011 | 68 | 0.090 |
Why?
|
| Methamphetamine | 1 | 2012 | 93 | 0.090 |
Why?
|
| Incidence | 1 | 2015 | 1661 | 0.080 |
Why?
|
| Macrophages | 2 | 2004 | 601 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2020 | 1086 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 359 | 0.080 |
Why?
|
| Heart Failure | 1 | 2020 | 1341 | 0.080 |
Why?
|
| Central Nervous System Stimulants | 1 | 2012 | 223 | 0.080 |
Why?
|
| Immunity | 1 | 2010 | 149 | 0.080 |
Why?
|
| Pubic Bone | 1 | 2008 | 9 | 0.070 |
Why?
|
| Accidents, Aviation | 1 | 2008 | 4 | 0.070 |
Why?
|
| Rupture | 1 | 2008 | 60 | 0.070 |
Why?
|
| Hemangioma, Cavernous | 1 | 2008 | 69 | 0.070 |
Why?
|
| Incidental Findings | 1 | 2008 | 98 | 0.070 |
Why?
|
| Injections, Intraperitoneal | 1 | 2008 | 101 | 0.070 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2008 | 31 | 0.070 |
Why?
|
| Graft Survival | 1 | 2011 | 935 | 0.070 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2007 | 45 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2009 | 331 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2016 | 4474 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 2730 | 0.070 |
Why?
|
| Serum Amyloid A Protein | 1 | 2007 | 24 | 0.070 |
Why?
|
| Fractures, Bone | 1 | 2008 | 148 | 0.070 |
Why?
|
| Immune System | 1 | 2008 | 102 | 0.070 |
Why?
|
| Length of Stay | 1 | 2010 | 790 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 85 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2008 | 670 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2007 | 299 | 0.060 |
Why?
|
| Intensive Care Units | 2 | 2021 | 429 | 0.060 |
Why?
|
| Acute Disease | 1 | 2008 | 855 | 0.060 |
Why?
|
| Graft Rejection | 1 | 2011 | 1110 | 0.060 |
Why?
|
| Cryotherapy | 1 | 2005 | 30 | 0.060 |
Why?
|
| Models, Animal | 1 | 2007 | 281 | 0.060 |
Why?
|
| Treatment Refusal | 1 | 2005 | 62 | 0.060 |
Why?
|
| Trust | 1 | 2005 | 98 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 3775 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2011 | 2368 | 0.050 |
Why?
|
| Laser Therapy | 1 | 2005 | 151 | 0.050 |
Why?
|
| Peripartum Period | 1 | 2024 | 29 | 0.050 |
Why?
|
| Complement System Proteins | 1 | 2004 | 83 | 0.050 |
Why?
|
| Chemokine CCL2 | 1 | 2003 | 48 | 0.050 |
Why?
|
| Infant | 1 | 2010 | 3206 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2004 | 277 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2003 | 161 | 0.050 |
Why?
|
| Violence | 1 | 2024 | 147 | 0.050 |
Why?
|
| Age Distribution | 1 | 2022 | 206 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 808 | 0.040 |
Why?
|
| Cause of Death | 1 | 2022 | 270 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2022 | 213 | 0.040 |
Why?
|
| Florida | 1 | 2021 | 60 | 0.040 |
Why?
|
| Hypertension | 1 | 2007 | 763 | 0.040 |
Why?
|
| Inflammation | 1 | 2007 | 1024 | 0.040 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2020 | 5 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2005 | 630 | 0.040 |
Why?
|
| Skin | 1 | 2003 | 595 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2003 | 552 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 6918 | 0.040 |
Why?
|
| Manikins | 1 | 2019 | 41 | 0.040 |
Why?
|
| Amiodarone | 1 | 2018 | 14 | 0.040 |
Why?
|
| Critical Pathways | 1 | 2018 | 36 | 0.040 |
Why?
|
| Wound Closure Techniques | 1 | 2017 | 14 | 0.030 |
Why?
|
| Extremities | 1 | 2019 | 177 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 402 | 0.030 |
Why?
|
| Medicare | 1 | 2021 | 440 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 2017 | 62 | 0.030 |
Why?
|
| Bandages | 1 | 2017 | 46 | 0.030 |
Why?
|
| Debridement | 1 | 2017 | 59 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 3054 | 0.030 |
Why?
|
| Health Resources | 1 | 2017 | 80 | 0.030 |
Why?
|
| Pregnancy | 1 | 2024 | 3113 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 1279 | 0.030 |
Why?
|
| Bacterial Translocation | 1 | 2016 | 26 | 0.030 |
Why?
|
| Peroxidase | 1 | 2016 | 53 | 0.030 |
Why?
|
| Heart Rate | 1 | 2018 | 502 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2016 | 229 | 0.030 |
Why?
|
| Leukocyte Disorders | 1 | 2014 | 2 | 0.030 |
Why?
|
| Chemokine CXCL1 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Immune System Diseases | 1 | 2014 | 27 | 0.030 |
Why?
|
| Yellow Fever | 1 | 2012 | 7 | 0.020 |
Why?
|
| Remission, Spontaneous | 1 | 2012 | 53 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2014 | 207 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 899 | 0.020 |
Why?
|
| Stroke | 1 | 2021 | 1038 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2011 | 131 | 0.020 |
Why?
|
| Watchful Waiting | 1 | 2012 | 69 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2011 | 67 | 0.020 |
Why?
|
| Microscopy | 1 | 2011 | 88 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2010 | 19 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 5708 | 0.020 |
Why?
|
| Alcoholic Intoxication | 1 | 2010 | 37 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2011 | 301 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 498 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 867 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1938 | 0.020 |
Why?
|
| Mesentery | 1 | 2003 | 44 | 0.010 |
Why?
|
| Wound Healing | 1 | 2003 | 371 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 3872 | 0.010 |
Why?
|